EUVIMEDEUVIMED entdecken
Crossref

Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS‐SOS1 Interaction

Saima Ikram, Ehsan Sayyah, Serdar Durdağı iD

ChemBioChem · 2024

DOI: 10.1002/cbic.202400008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Saima Ikram und 2 weiteren Autor:innen. Beteiligte Einrichtung: Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahçeşehir University, 34734, Istanbul, Tur…. Hauptthemen laut MEDLINE: SOS1 Protein, Small Molecule Libraries, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The RAS‐MAPK signaling pathway, crucial for cell proliferation and differentiation, involves key proteins KRAS and SOS1. Mutations in the KRAS and SOS1 genes are implicated in various cancer types, including pancreatic, lung, and juvenile myelomonocytic leukemia. There is considerable interest in identifying inhibitors targeting KRAS and SOS1 to explore potential therapeutic strategies for cancer treatment. In this study, advanced in silico techniques were employed to screen small molecule libraries at this interface, leading to the identification of promising lead compounds as potential SOS1 inhibitors. Comparative analysis of the average binding free energies of these predicted potent compounds with known SOS1 small molecule inhibitors revealed that the identified compounds display similar or even superior predicted binding affinities compared to the known inhibitors. These findings offer valuable insights into the potential of these compounds as candidates for further development as effective anti‐cancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SOS1 ProteinSmall Molecule LibrariesProto-Oncogene Proteins p21(ras)HumansAntineoplastic AgentsMolecular Docking SimulationProtein BindingDrug Evaluation, Preclinical

Stichwörter der Autor:innen

KRASMD simulationsSOS1 inhibitormolecular dockingprotein-protein interactionsteered MD simulationsvirtual screening

Substanzen

SOS1 ProteinSmall Molecule LibrariesProto-Oncogene Proteins p21(ras)KRAS protein, humanSOS1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahçeşehir University, 34734, Istanbul, Turkey.
  • Lab for Innovative Drugs (Lab4IND), Computational Drug Design Center (HİTMER), Bahçeşehir University, 34734, İstanbul, Türkiye.
  • Molecular Therapy Lab (MTL), Department of Pharmaceutical Chemistry, School of Pharmacy, Bahçeşehir University, 34353, Istanbul, Türkiye.

ORCID-Profile: Serdar Durdağı

Zitieren

APA

Ikram, S., Sayyah, E., & Durdağı, S. (2024). Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS‐SOS1 Interaction. ChemBioChem. https://doi.org/10.1002/cbic.202400008

Vancouver

Ikram S, Sayyah E, Durdağı S. Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS‐SOS1 Interaction. ChemBioChem. 2024. doi:10.1002/cbic.202400008

BibTeX
@article{Ikram2024,
  author = {Ikram, Saima and Sayyah, Ehsan and Durdağı, Serdar},
  title = {Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS‐SOS1 Interaction},
  journal = {ChemBioChem},
  year = {2024},
  doi = {10.1002/cbic.202400008}
}
Kostenlos starten →